Atlas Trials

The Safety and Efficiency of Sildenafil in the Treatment of Severe Post-capillary Pulmonary Hypertension Caused by COPD

Clinical trial NCT03185364 · UNKNOWN

Trial details

NCT number
NCT03185364
Sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
COPDPulmonary Hypertension
Start date
2017-06-15
Primary completion
2020-12-31
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.